Moreover, because TRAF6 and IRAK1 are negative regulators of toll-like receptor signaling and NF-κB [72,73], we anticipated a beneficial influence on the ALS iAstrocyte reactive profile. Here, IRAK1 is linked to amyotrophic lateral sclerosis.